Clinical Trials List
Protocol NumberCBKM120F2202
2012-08-01 - 2015-12-31
Phase II
Terminated3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林璟宏 Division of Hematology & Oncology
- 陳怡君 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tsu-Yi Chao Division of Hematology & Oncology
- Wei-Hwa Lee Division of Others -
- 蘇志銘 Division of General Surgery
- 蘇勇誠 Division of Hematology & Oncology
- CHIH-MING SU Division of General Surgery
- 謝耀宇 Division of Hematology & Oncology
- 林漢斌 Division of Hematology & Oncology
- Jacqueline Whang-Peng Division of Hematology & Oncology
- 吳志雄 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
200 participants
